参考文献/References:
[1] Ahmedin Jemal, Rebecca Siegel, Jiaquan Xu, et al. Cancer statistics, 2010[M]. CA Cancer J Clin, 2010, 60: 227-300.
[2] Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths[J]. CA Cancer J Clin, 2011, 61(4): 212-236.
[3] Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates[J]. Eur Urol, 2012, 61(6): 1079-1092.
[4] Satomi, A. Significance of significance of increased neutrophils in patients with advanced colorectal-cancer[J]. Acta Oncol (Madr), 1995, 34(1): 69-73.
[5] Hirashima M, Higuchi S, Sakamoto K, et al. The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer[J]. J Cancer Res Clin Oncol, 1998, 124(6): 329-334.
[6] Gondo T, Nakashima J, Ohno Y, et al. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy [J]. Urology, 2012, 79 (5): 1085-1091.
[7] Kemal Y1, Yucel I, Ekiz K, et al. Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis [J]. Asian Pac J Cancer Prev, 2014, 15(6): 2651-2654.
[8] Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?[J]. Lancet, 2001, 357(9255): 539-545.
[9] Coussens LM, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420(6917): 860-867.
[10] Colotta F, Allavens P, Sica A, et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability [J]. Carcinogenesis, 2009, 30(7): 1073-1081.
[11] Kusumanto YH, Dam WA, Hosper GA, et al. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor [J]. Angiogensis, 2003, 6: 283-287.
[12] Mcdonald B, Spicer J, Giannails B, et al. Systemic information increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms[J]. Int J Cancer, 2009, 123(6): 1298-1305.
[13] Gomez D, Farid S, Malik HZ, et al. Preoperative neutrophiltolymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma [J]. World J Surg, 2008, 32 (8): 1757-1762
[14] Shimada H, Takiguchi N, Kainuma O, et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer[J]. Gastric Cancer, 2010, 13(3): 170-176.
[15] Cho H, Hur HW, Kim SW, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment[J]. Cancer Immunol Immunother, 2009, 58(1): 15-23.
[16] Keizman D, Ish-Shalom M, Huang P, et al. The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma[J]. Eur J Cancer, 2012, 48(2): 202-208.
[17] Keizman D1, Gottfried M, Ish-Shalom M, et al. Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram [J]. Oncologist, 2012, 17 (12): 1508-1514.
[18] Azuma T, Matayoshi Y, Odani K, et al. Preoperative neutrophil-lymphocyte ratio as an Independent prognostic marker for patients with upper urinary tract urothelial carcinoma[J]. Clin Genitourin Cancer, 2013, 11(3): 337-341.
[19] Gomez D, Farid S, Malik HZ, et al. Preoperative neutrophilto-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma [J]. World J Surg, 2008, 32 (8): 1757-1762.
相似文献/References:
[1]李辽源,高新,李解方,等.血清/尿PSA比值对血清PSA处于"灰区"中前列腺癌的诊断价值[J].中华腔镜泌尿外科杂志(电子版),2008,(03):52.
LI Liao-yuan,GAO Xin,LI Xie-fang,et al.The role of the ratio of serum PSA and urine PSA in diagnosing prostate carcinoma within the serum PSA "gray" zone[J].,2008,(05):52.
[2]仲飞,郝吉庆,孙国平.多西他赛联合卡培他滨治疗激素抵抗性晚期前列腺癌的近期疗效[J].中华腔镜泌尿外科杂志(电子版),2011,(04):278.
ZHONG Fei,HAO Jiqing,SUN Guo-ping.Effects of docetaxel and capecitabine for hormone-refractory prostate cancer[J].,2011,(05):278.
[3]何必鸣,陈锐,高旭,等.前列腺癌术后病理较穿刺病理Gleason 评分升高的相关因素[J].中华腔镜泌尿外科杂志(电子版),2016,10(02):77.[doi:10.3877/cma.j.issn.1674-3253.2016.02.002]
[4]周骏,梁朝朝,施浩强,等.腹腔镜前列腺癌根治术的技术改良与再认识[J].中华腔镜泌尿外科杂志(电子版),2016,10(02):80.[doi:10.3877/cma.j.issn.1674-3253.2016.02.003]
[5]罗子寰,陆敏华,黄群雄,等.DOPEY2 在TMPRSS2-ERG 基因融合
阴性前列腺癌中的表达及临床意义[J].中华腔镜泌尿外科杂志(电子版),2016,10(02):127.[doi:10.3877/cma.j.issn.1674-3253.2016.02.015]
[6]施振凯,高旭,王海峰,等.机器人辅助筋膜内前列腺癌根治术对术后尿控影响的研究[J].中华腔镜泌尿外科杂志(电子版),2016,10(01):8.[doi:10.3877/cma.j.issn.1674-3253.2016.01.003
]
Shi Zhenkai,Gao Xu,Wang Haifeng,et al.Urinary function of intrafascial robot-assisted laparoscopic radical prostatectomy[J].,2016,10(05):8.[doi:10.3877/cma.j.issn.1674-3253.2016.01.003
]
[7]林立国,吴国忠,孙忠凯,等.经尿道前列腺电切术诊治高度疑似晚期前列腺癌并膀胱出口梗阻[J].中华腔镜泌尿外科杂志(电子版),2016,10(04):230.[doi:10.3877/cma.j.issn.1674-3253.2016.04.004
]
Lin Liguo,Wu Guozhong,Sun Zhongkai,et al.Transurethral resection of prostate to diagnose and treat the patients with highly suspected advanced prostate cancer and lower urinary tract symptoms[J].,2016,10(05):230.[doi:10.3877/cma.j.issn.1674-3253.2016.04.004
]
[8]杨波 邓晓俊 温晓飞 陈卫华 刘辉 刘峰 王伟峰 郝继东 万建省 廖国强.经直肠弹性超声穿刺活检联合墨水标记法病理诊断前列腺癌的研究[J].中华腔镜泌尿外科杂志(电子版),2016,10(05):296.[doi:10.3877/cma.j.issn.1674-3253.2016.05.002
]
Yang Bo,DengXiaojun,WenXiaofei,et al.The clinical research of biopsy of prostate cancer by transrectal ultrasound elastography combined ink marking[J].,2016,10(05):296.[doi:10.3877/cma.j.issn.1674-3253.2016.05.002
]
[9]杨逢生,李宝兴,刘文泓,等.经腹与经腹膜外途径腹腔镜前列腺癌根治术疗效比较的Meta分析[J].中华腔镜泌尿外科杂志(电子版),2016,10(05):301.[doi:10.3877/cma.j.issn.1674-3253.2016.05.003
]
Yang Fengsheng,Li Baoxing,Liu Wenhong,et al.Comparison of transperitoneal and extraperitoneal laparoscopic radical prostatectomy: a Meta analysis[J].,2016,10(05):301.[doi:10.3877/cma.j.issn.1674-3253.2016.05.003
]
[10]赖义明 钟娴 陈贤举 袁立燕 章颖 郑瑞映 谢鸿玉 王昕 黄海 郭正辉.前列腺癌血管形成机制研究进展[J].中华腔镜泌尿外科杂志(电子版),2016,10(06):423.[doi:10.3877/cma.j.issn.1674-3253.2016.06.014
]